Literature DB >> 14254816

REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).

M M BEST, C H DUNCAN.   

Abstract

Entities:  

Keywords:  ANDROSTERONE; ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BUTYRATES; CLINICAL RESEARCH; CORONARY DISEASE; DRUG THERAPY; GERIATRICS; GLYCERIDES; HYPERCHOLESTEREMIA; HYPERLIPEMIA; PLACEBOS

Mesh：

Substances：

Year:  1965        PMID： 14254816     DOI： 10.1016/0002-9149(65)90459-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  6 in total

Review 1.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

2.  Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.

Authors:  A M Barrett; J M Thorp
Journal:  Br J Pharmacol Chemother       Date:  1968-02

3.  [Drug treatment of primary hyperlipoproteinemia (author's transl)].

Authors:  G Klose; R Mordasini; G Middelhoff; J Augustin; H Greten
Journal:  Klin Wochenschr       Date:  1978-02-01

4.  Modulation of fatty acid-binding protein content of adult rat heart in response to chronic changes in plasma lipid levels.

Authors:  A Garnier; C Poizat; C Keriel; P Cuchet; M M Vork; Y F de Jong; J F Glatz
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

5.  Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.

Authors:  P Cuchet; C Morrier; F Cand; C Keriel
Journal:  Lipids       Date:  1981-10       Impact factor: 1.880

6.  Modification of intracellular glucose metabolism in human skin fibroblast preincubated with p-chlorophenoxyisobutyrate.

Authors:  T Nishide; K Shirai; Y Saito; S Yoshida
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.